Peregrine Pharmaceuticals shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Peregrine Pharmaceuticals (CDMO) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Peregrine Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Peregrine Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Peregrine Pharmaceuticals by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-12-31 | $1.8M | 142k | 12.35 |
| 2024-09-30 | $1.2M | 109k | 11.38 |
| 2024-06-30 | $203k | 28k | 7.14 |
| 2024-03-31 | $174k | 26k | 6.70 |
| 2023-12-31 | $573k | 88k | 6.50 |
| 2023-09-30 | $733k | 78k | 9.44 |
| 2023-06-30 | $1.2M | 88k | 13.97 |
| 2023-03-31 | $627k | 852 | 735.59 |
| 2022-12-31 | $969k | 70k | 13.83 |
| 2022-06-30 | $858k | 56k | 15.24 |
| 2022-03-31 | $936k | 46k | 20.36 |
| 2021-12-31 | $1.1M | 39k | 29.17 |
| 2021-03-31 | $4.2M | 232k | 18.23 |
| 2020-12-31 | $1.9M | 163k | 11.43 |
| 2020-09-30 | $195k | 25k | 7.71 |
| 2020-06-30 | $570k | 87k | 6.57 |
| 2020-03-31 | $786k | 153k | 5.13 |
| 2019-12-31 | $1.0M | 134k | 7.70 |
| 2019-09-30 | $504k | 94k | 5.37 |
| 2019-06-30 | $78k | 20k | 3.97 |
| 2019-03-31 | $549k | 129k | 4.25 |
| 2018-12-31 | $541k | 132k | 4.09 |
| 2018-09-30 | $108k | 16k | 6.76 |
| 2018-06-30 | $225k | 57k | 3.97 |
| 2018-03-31 | $294k | 97k | 3.03 |